Revision: Oct. 3, 2023, 1:39 p.m.
2024 SESSION
24-2115.0
05/10
HOUSE BILL [bill number]
AN ACT relative to qualifying medical conditions for purposes of therapeutic cannabis.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill adds debilitating or terminal medical conditions to the qualifying medical conditions for therapeutic cannabis if a health care provider certifies the potential benefit to the patient. The bill also removes certain limitations on a qualifying visiting patient's access to cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2115.0
05/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to qualifying medical conditions for purposes of therapeutic cannabis.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Subparagraph; Qualifying Medical Conditions for Purposes of Therapeutic Cannabis; Debilitating or Terminal Medical Conditions. Amend RSA 126-X:1, IX(b) by inserting after subparagraph (6) the following new subparagraph:
(7) For adults 21 years of age or older, any debilitating or terminal medical condition or symptom for which the potential benefits of using therapeutic cannabis would, in the provider’s clinical opinion, likely outweigh the potential health risks for the patient. In order to certify a patient under this category, a certifying provider shall include on the written certification the patient’s specific condition or symptom and attest to their clinical opinion.
2 Repeal. RSA 126-X:2, V(a), relative to limitations for a visiting qualifying patient, is repealed.
3 Effective Date. This act shall take effect 60 days after its passage.